Find News

Filter articles

Showing 71 to 80 of 3807 results

FTC wades into escalating ‘Orange Book’ clash

US15-11-2022Staff Writer

Jazz accused a rival of infringement | Avadel filed a counterclaim seeking to delist the patent from the Orange Book.

English appeals court rejects jurisdiction challenge over cannabis sativa collab

10-11-2022Staff writer

Case concerns epilepsy drug patent and medical cannabis R&D collaboration | Dispute between Japanese and Irish pharma firms will be heard in London due to arbitration carve-out clause.

SCOTUS rejects BMS vs Gilead patent clash

US10-11-2022Staff Writer

Dispute over patent relating to a CAR-T cell therapy shunned by top court | Backing from Amgen, GSK and St. Jude's Children's Research Hospital over “exceedingly narrow” patent protection fails to convince Justices.

Spruson & Ferguson adds litigator to life sciences team


Spruson & Ferguson has hired litigator Katrina Crooks as a principal, who will join its office in Sydney.

NGOs attack UK’s ‘disastrous’ IP proposals to India

India08-11-2022Staff Writer

Humanitarian organisations censure leaked IP provisions within UK-India free trade agreement | “Excessive measures” would “drastically harm access” to affordable, lifesaving generic medicines from India.

SCOTUS agrees to hear Amgen revival bid

US07-11-2022Staff Writer

The dispute centres on a section of the Patent Act concerning 'enablement' | The US government had urged the court to deny the petition.

Analysis: Ventria on ITC win barring rHSA products

US03-11-2022Sarah Speight

Counsel for Ventria sat down with Sarah Speight to explore their landmark win at the International Trade Commission, which led to a US ban for a Chinese company

Patent firm’s Sweden office expands with partner hire


Patent law firm EIP has hired Pontus Falk as a partner at its recently opened Sweden office.

Big pharma co buys $16.6bn for heart tech company

US02-11-2022Staff Writer

Cardiovascular ‘innovator’ snapped up as company strengthens medtech offering | Massachusetts-based Abiomed will become part of purchaser’s medtech division

Pharma firm voluntarily licences cancer drug in novel deal


Agreement is 'first ever' public health focused voluntary licensing deal on a cancer medicine| Opportunities for generic manufacturers

Showing 71 to 80 of 3807 results